期刊文献+

应用中国仓鼠卵巢细胞法检测百日咳毒素毒性方法的建立及初步验证 被引量:3

Establishment and primary validation of Chinese hamster ovary cell-based assay for determination of residual toxicity of pertussis toxin
原文传递
导出
摘要 目的 建立用中国仓鼠卵巢(Chinese hamster ovary,CHO)细胞检测百日咳毒素(pertussis toxin,PT)毒性的方法,并对其适用性进行初步验证.方法 根据PT能特异地使CHO细胞簇集的特性,以国家PT标准品为参考品,取多批脱毒后PT进行检测,摸索适宜的孵育时间、细胞悬液浓度等实验条件,建立PT毒性的体外检测方法.对PT参考品进行倍比系列稀释,确定本法的检测限.对5批脱毒后PT进行重复检测,验证本法的重复性.结果 利用不同浓度CHO细胞对脱毒PT进行测定,确定最佳细胞浓度为5×104/ml,并通过最佳浓度细胞确定簇集结果的最佳判定时间为PT接种后48 h.本法对PT标准品的检测限定为125.0~ 500.0 pg/ml.用本法重复测定5批脱毒PT的残余毒性,变异系数为0.0%~34.6%,说明该法重复性良好.结论 建立的CHO细胞检测法快捷、简便,能灵敏、准确地检测脱毒PT的残余毒性,可用于相关疫苗产品的质量控制. Objective To establish Chinese hamster ovary cell clustering method for determination of residual toxicity of pertussis toxin (PT) and validate its applicability.Methods The PT national standard was used as a reference and several lots of detoxified PTs as samples.The optimal incubation time and cell concentration were explored to establish the method for determination of PT toxicity in vitro.Meanwhile,the detection limit was determined by doubling dilution of the PT reference.The repeatability of the method was validated by repeat detection of 5 lots of detoxified PTs.Results The optimal CHO cell concentration and incubation time were 5 × 104/ml and 48 h after inoculation of PT,respectively.The detection limit ranged from 125.0 to 500.0 pg/ml.The coefficient of variation was 0.0%-34.6%,suggesting that the method had a good repeatability.Conclusion The method developed is rapid,sensitive and reliable,and could be used for quality control of residual toxicity in vaccine products.
出处 《国际生物制品学杂志》 CAS 2013年第6期284-287,共4页 International Journal of Biologicals
关键词 百日咳毒素 百日咳菌苗 中国仓鼠卵巢细胞 验证 Pertussis toxin Pertussis vaccine Chinese hamster ovary cells Validation
  • 相关文献

参考文献7

  • 1侯启明,张庶民,梁雅文,等.第一代无细胞百日咳疫苗毒性国家参考品制备工艺的研究[J].药物评价,2005,2(6):423-424.
  • 2Corbel M J,Kreeftenberg JG,Knezevic I.WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003,Ferney Voltaire,France[J].Vaccine,2004,22 (3/4):293-300.
  • 3(O)stergaard E,S(o)rensen C,Nielsen L,et al.Elimination of interfering activity in serum samples in the Chinese hamster ovary pertussis serology assay[J].Clin Vaccine Immunol,2008,15(8):1244-1247.
  • 4Sato Y,Sato H.Development of acellular pertussis vaccines[J].Biologicals,1999,27 (2):61-69.
  • 5Lugauer S,Heininger U,Cherry JD,et al.Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine[J].Eur J Pediatr,2002,161 (3):142-146.
  • 6孙述学,何长民.无细胞百日咳疫苗的质量控制及其标准化[J].微生物学免疫学进展,2001,29(1):83-86. 被引量:2
  • 7Hewlett EL,Sauer KT,Myers GA,et al.Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin[J].Infect Immun,1983,40(3):1198-1203.

二级参考文献1

  • 1-.WHO召开的百日咳菌苗非官方研讨会[J].中国生物制品学杂志,1998,11(3):190-192.

共引文献1

同被引文献20

  • 1董关木.细胞培养用牛血清现状与进展[J].中国生物制品学杂志,2007,20(9):697-700. 被引量:26
  • 2侯启明,张路民,梁雅文,秦进才.应用CHO细胞法检测百日咳疫苗中的残余毒性[J].中国生物制品学杂志,1997,10(2):101-103. 被引量:4
  • 3Yuen CT,Horiuchi Y,Asokanathan C,et al.An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines[J].Vaccine,2010,28(21):3714-3721.
  • 4Xing D,Yuen CT,Asokanathan C,et al.Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines[J].Biologicals,2012,40(6):456-465.
  • 5Gillenius P,Jtmaa E,Askelf P,et al.The standardization of an assay for pertussis toxin and titoxin in microplate culture of Chinese hamster ovary cells[J].J Biol Stand,1985,13(1):61-66.
  • 6Hewlett EL,Sauer KT,Myers GA,et al.Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin[J].Infect Immun,1983,40(3):1198-1203.
  • 7European Pharmacopoeia Commission.European Pharmacopoeia(7.0)[S].Strasbourg:European Directorate for the Quality of Medicines&Health Care,2010:806-807.
  • 8European Pharmacopoeia Commission.European Pharmacopoeia(7.0)[S].Strasbourg:European Directorate for the Quality of Medicines&Health Care,2010:808-809.
  • 9World Health Organization.Manual for quality control of diphtheria,tetanus pertussis and combined vaccines[S].2013-05-01:192-197.
  • 10Corbel MJ,Kreeftenberg JG,Knezevic I.WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003,Ferney Voltaire,France[J].Vaccine,2004,22(3/4):293-300.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部